STTKShattuck Labs, Inc.

Nasdaq shattucklabs.com


$ 4.36 $ 0.21 (4.92 %)    

Friday, 21-Jun-2024 15:59:56 EDT
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 4.37
$ 4.20
$ 0.00 x 0
$ 0.00 x 0
$ 4.19 - $ 4.42
$ 1.33 - $ 11.76
460,485
na
220.98M
$ 0.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-16-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-shattuck-labs-lowers-price-target-to-16

HC Wainwright & Co. analyst Joseph Pantginis maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price targe...

 citigroup-maintains-buy-on-shattuck-labs-lowers-price-target-to-9

Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $10 to...

 needham-maintains-buy-on-shattuck-labs-lowers-price-target-to-8

Needham analyst Gil Blum maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $12 to $8.

 shattuck-labs-discloses-updated-interim-data-from-phase-1b-dose-expansion-clinical-trial-of-sl-172154-in-combination-with-azacitidine-in-frontline-higher-risk-myelodysplastic-syndromes-and-tp53-mutant-acute-myeloid-leukemia-patients

The company observed 67% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial com...

 hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

 needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

 needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

 shattuck-labs-q1-2024-gaap-eps-037-beats-046-estimate-sales-1115m-beat-228500k-estimate

Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.46)...

 shattuck-labs-reports-preclinical-data-demonstrating-therapeutic-utility-of-trim7-inhibition-to-prevent-or-reverse-acquired-resistance-to-immune-checkpoint-therapy

These data were featured in an oral presentation during the AACR Annual Meeting 2024, being held from April 5-10, 2024, in San ...

 needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

 needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

 shattuck-labs-q4-eps-041-beats-057-estimate

Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.57)...

 hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...